End Stage Renal Disease (ESRD) Clinical Trial
Official title:
Effect of a Low AGE Diet on Human Microbiome
This is an intervention study of the effects of food preparation on the gut bacteria in patients with end stage renal disease on peritoneal dialysis. This is a dietary intervention consistent of consuming low amounts of advanced glycation end products (AGEs), the products of protein and sugar interaction during food processing and preparation using high direct heat.
Gut microbes can influence numerous aspects of human biology. Alterations in the function and composition of gut microbial flora (gut microbiota) have been linked to different diseases such as obesity, diabetes and inflammation. Advanced Glycation End products (AGEs) are formed via the Maillard reaction, which consists of a complex network of non-enzymatic reactions involving the carbonyl groups of reducing sugars which react with the amino groups of proteins. AGEs are produced in vivo and being consumed. They have been implicated in increased risk of different diseases including atherosclerosis, CAD and kidney diseases. In this study, the investigators are evaluating the effects of consuming a low AGE diet in participants on peritoneal dialysis on the gut bacteria and inflammation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05908084 -
To Compare the Efficacy and Safety of the HAV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
|
Phase 3 | |
| Active, not recruiting |
NCT05309109 -
Effect of Medium Cut-Off Hemodialysis on Protein Energy Wasting: The EMCOPEW Study
|
N/A | |
| Not yet recruiting |
NCT04086212 -
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
|
Phase 2 | |
| Completed |
NCT01783626 -
Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)
|
N/A | |
| Active, not recruiting |
NCT01693263 -
Outcome of BCF Access in Hemodialysis Patients
|
||
| Completed |
NCT01219959 -
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
|
Phase 3 | |
| Completed |
NCT02278341 -
Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
|
Phase 3 | |
| Completed |
NCT02593149 -
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
|
N/A | |
| Withdrawn |
NCT02274896 -
Bayston Multicenter Antimicrobial PD Catheter Safety Study
|
N/A | |
| Completed |
NCT04912050 -
EXtension of Tablo TrEatmeNt Duration Registry
|
||
| Recruiting |
NCT02745340 -
Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis
|
N/A | |
| Completed |
NCT02733328 -
Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
|
||
| Completed |
NCT04292184 -
Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation
|
Phase 1 | |
| Completed |
NCT02795286 -
Automated Setting of Individualized Sodium Technology
|
N/A | |
| Active, not recruiting |
NCT02808208 -
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
|
Phase 1/Phase 2 | |
| Completed |
NCT00559767 -
Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium
|
N/A | |
| Completed |
NCT02433210 -
A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients
|
N/A | |
| Completed |
NCT01594424 -
A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT05610683 -
Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers
|
N/A | |
| Completed |
NCT03249532 -
Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis
|
N/A |